Identification of Ephrin type-B receptor 4 as a critical mediator of tissue fibrosis
Authors:
- Brian WuBWBrian Wu
- Starlee S. LivelySLStarlee S. Lively
- Shabana VohraSVShabana Vohra
- Noah FineNFNoah Fine
- Chiara PastrelloCPChiara Pastrello
- Anca MaglaviceanuAMAnca Maglaviceanu
- Osvaldo Espin-GarciaOEOsvaldo Espin-Garcia
- Evan Pollock-TahiriEPEvan Pollock-Tahiri
- Sayaka NakamuraSNSayaka Nakamura
- Paramvir KaurPKParamvir Kaur
- Jason S. RockelJRJason S. Rockel
Open Access
- 22 December 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (24)
Abstract
Pulmonary fibrosis (PF) is a pathology associated with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). Fibrosis promotes continual secretion of extracellular matrix (ECM), producing nonfunctional scar tissue and causing organ failure. This study investigated the tyrosine kinase receptor Ephrin type-B receptor 4 (EphB4) as a mediator of PF. To this end, we generated mice with conditional Col1a2- driven deletion of Ephb4 and used a preclinical mouse model of PF, total and single nuclei RNA (snRNA) sequencing, NanoString, previously published single-cell data, computational analysis, and functional assays of mouse and human healthy control and IPF lung fibroblasts. Col1a2 -Cre ERT –driven Ephb4 deletion, or EphB4 inhibition via NVP-BHG712, markedly protected against bleomycin-induced PF. Total RNA-Seq of fibroblasts isolated from Ephb4 -deficient fibrotic mouse lungs exhibited reduced expression of ECM, ER Cargo, and protein trafficking–related genes. NVP-BHG712 reduced expression of these identified genes in mouse lung fibroblasts under fibrotic conditions in vitro. snRNA-Seq of mouse lungs treated with NVP-BHG712 identified transcriptomic changes of ECM genes in specific fibroblast subpopulations. RNA-Seq, computational, and functional assays using mouse and human IPF fibroblasts identified elastin as a key mediator involved in EphB4 signaling. Combined, our data show that EphB4 is a crucial mediator of PF.Keywords
All Related Versions
Funding Information
- National Science and Engineering Research Council (Discovery Grant)
- Canada Research Chairs (Tier 1 Canada Research Chair Award)
- University Health Network Foundation (Tony)
- University Health Network Foundation (Shari Fell Platinum Chair)
This publication has 50 references indexed in Scilit:
- Integrated analysis of multimodal single-cell dataCell, 2021
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Fibroblasts and their responses to chronic injury in pulmonary fibrosisSeminars in Arthritis and Rheumatism, 2021
- MicroRNA‐34a‐5p Promotes Joint Destruction During OsteoarthritisArthritis & Rheumatology, 2020
- Ephrins and Eph Receptor Signaling in Tissue Repair and FibrosisCurrent Rheumatology Reports, 2019
- DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest NeighborsCell Systems, 2019
- Distinct Mesenchymal Lineages and Niches Promote Epithelial Self-Renewal and Myofibrogenesis in the LungCell, 2017
- Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct?Arthritis & Rheumatology, 2014
- Effect of reduced EPHB4 expression in thymic epithelial cells on thymocyte development and peripheral T cell functionMolecular Immunology, 2014
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisAngiogenesis, 2010